Detalles de la búsqueda
1.
Recent Progress in Phage-Based Nanoplatforms for Tumor Therapy.
Small
; 20(7): e2307111, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806755
2.
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study.
Ann Hematol
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38662205
3.
Analysis of prognostic factors affecting immune checkpoint inhibitor therapy in tumor patients exposed to antibiotics.
Front Oncol
; 13: 1204248, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37483503
4.
The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma.
J Oncol
; 2022: 2900310, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483984
5.
The value of ultrasound-guided fine needle aspiration in the diagnosis of diffuse large B-cell lymphoma: A single center experiment.
Eur J Radiol
; 157: 110567, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283194
6.
Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL.
Blood Adv
; 7(6): 1070-1075, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35901280
7.
[Effect of brentuximab vedotin combined with chlormethine hydrochloride on the treatment of 6 patients with relapsed and refractory Hodgkin lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 36(7): 575-7, 2015 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-26304081
Resultados
1 -
7
de 7
1
Próxima >
>>